Dose Titration and Safety Profile of Aficamten in Nonobstructive Hypertrophic Cardiomyopathy: Findings from ACACIA-HCM

Cytokinetics Incorporated published this content on October 12, 2026, and is solely responsible for the information contained herein. Distributed via Public Technologies (PUBT), unedited and unaltered, on October 12, 2026 at 16:20 UTC. If you believe the information included in the content is inaccurate or outdated and requires editing or removal, please contact us at [email protected]